Sign in
4

Changes in Ownership

Oric Pharmaceuticals, Inc. Filed Acc 0001209191-22-038199

Options or other derivatives

  • Director acquired 50,283 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Hoerter Steven L. Director 2022-06-17 Grant or award · Stock Option (right to buy) +50,283 50,283 D
Loading xslF345X03/doc4.xml…